Endothelial dysfunction in diabetes

Multiple targets for treatment

Research output: Contribution to journalReview article

72 Citations (Scopus)

Abstract

Robert Furchgott's discovery of the obligatory role that the endothelium plays in the regulation of vascular tone has proved to be a major advance in terms of our understanding of the cellular basis of diabetic vascular disease. Endothelial dysfunction, as defined by a reduction in the vasodilatation response to an endothelium-dependent vasodilator (such as acetylcholine) or to flow-mediated vasodilatation, is an early indicator for the development of the micro- and macroangipathy that is associated with diabetes. In diabetes, hyperglycaemia plays a key role in the initiation and development of endothelial dysfunction; however, the cellular mechanisms involved as well as the importance of dyslipidaemia and co-morbidities such as hypertension and obesity remain incompletely understood. In this review, we discuss the mechanisms whereby hyperglycaemia, oxidative stress and dyslipidaemia can alter endothelial function and highlight their effects on endothelial nitric oxide synthase (eNOS), the endothelium-dependent hyperpolarising factor (EDHF) pathway(s), as well as on the role of endothelium-derived contracting factors (EDCFs) and adipocyte-derived vasoactive factors such as adiposederived relaxing factor (ADRF).

Original languageEnglish
Pages (from-to)977-994
Number of pages18
JournalPflugers Archiv European Journal of Physiology
Volume459
Issue number6
DOIs
Publication statusPublished - May 2010

Fingerprint

Medical problems
Endothelium
Dyslipidemias
Vasodilation
Endothelium-Dependent Relaxing Factors
Hyperglycemia
Oxidative stress
Nitric Oxide Synthase Type III
Acetylcholine
Diabetic Angiopathies
Adipocytes
Blood Vessels
Oxidative Stress
Obesity
Hypertension
Morbidity

Keywords

  • Diabetes
  • Endothelial dysfunction
  • Endothelium-derived contracting factors (EDCF)
  • Endothelium-derived hyperpolarising factor (EDHF)
  • Hyperglycaemia
  • Nitric oxide (NO)
  • Oxidative stress

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Physiology
  • Medicine(all)
  • Physiology (medical)

Cite this

Endothelial dysfunction in diabetes : Multiple targets for treatment. / Ding, Hong; Triggle, Christopher.

In: Pflugers Archiv European Journal of Physiology, Vol. 459, No. 6, 05.2010, p. 977-994.

Research output: Contribution to journalReview article

@article{7b71b56f558240d3b86ebaa37277e2d6,
title = "Endothelial dysfunction in diabetes: Multiple targets for treatment",
abstract = "Robert Furchgott's discovery of the obligatory role that the endothelium plays in the regulation of vascular tone has proved to be a major advance in terms of our understanding of the cellular basis of diabetic vascular disease. Endothelial dysfunction, as defined by a reduction in the vasodilatation response to an endothelium-dependent vasodilator (such as acetylcholine) or to flow-mediated vasodilatation, is an early indicator for the development of the micro- and macroangipathy that is associated with diabetes. In diabetes, hyperglycaemia plays a key role in the initiation and development of endothelial dysfunction; however, the cellular mechanisms involved as well as the importance of dyslipidaemia and co-morbidities such as hypertension and obesity remain incompletely understood. In this review, we discuss the mechanisms whereby hyperglycaemia, oxidative stress and dyslipidaemia can alter endothelial function and highlight their effects on endothelial nitric oxide synthase (eNOS), the endothelium-dependent hyperpolarising factor (EDHF) pathway(s), as well as on the role of endothelium-derived contracting factors (EDCFs) and adipocyte-derived vasoactive factors such as adiposederived relaxing factor (ADRF).",
keywords = "Diabetes, Endothelial dysfunction, Endothelium-derived contracting factors (EDCF), Endothelium-derived hyperpolarising factor (EDHF), Hyperglycaemia, Nitric oxide (NO), Oxidative stress",
author = "Hong Ding and Christopher Triggle",
year = "2010",
month = "5",
doi = "10.1007/s00424-010-0807-3",
language = "English",
volume = "459",
pages = "977--994",
journal = "Pflugers Archiv European Journal of Physiology",
issn = "0031-6768",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - Endothelial dysfunction in diabetes

T2 - Multiple targets for treatment

AU - Ding, Hong

AU - Triggle, Christopher

PY - 2010/5

Y1 - 2010/5

N2 - Robert Furchgott's discovery of the obligatory role that the endothelium plays in the regulation of vascular tone has proved to be a major advance in terms of our understanding of the cellular basis of diabetic vascular disease. Endothelial dysfunction, as defined by a reduction in the vasodilatation response to an endothelium-dependent vasodilator (such as acetylcholine) or to flow-mediated vasodilatation, is an early indicator for the development of the micro- and macroangipathy that is associated with diabetes. In diabetes, hyperglycaemia plays a key role in the initiation and development of endothelial dysfunction; however, the cellular mechanisms involved as well as the importance of dyslipidaemia and co-morbidities such as hypertension and obesity remain incompletely understood. In this review, we discuss the mechanisms whereby hyperglycaemia, oxidative stress and dyslipidaemia can alter endothelial function and highlight their effects on endothelial nitric oxide synthase (eNOS), the endothelium-dependent hyperpolarising factor (EDHF) pathway(s), as well as on the role of endothelium-derived contracting factors (EDCFs) and adipocyte-derived vasoactive factors such as adiposederived relaxing factor (ADRF).

AB - Robert Furchgott's discovery of the obligatory role that the endothelium plays in the regulation of vascular tone has proved to be a major advance in terms of our understanding of the cellular basis of diabetic vascular disease. Endothelial dysfunction, as defined by a reduction in the vasodilatation response to an endothelium-dependent vasodilator (such as acetylcholine) or to flow-mediated vasodilatation, is an early indicator for the development of the micro- and macroangipathy that is associated with diabetes. In diabetes, hyperglycaemia plays a key role in the initiation and development of endothelial dysfunction; however, the cellular mechanisms involved as well as the importance of dyslipidaemia and co-morbidities such as hypertension and obesity remain incompletely understood. In this review, we discuss the mechanisms whereby hyperglycaemia, oxidative stress and dyslipidaemia can alter endothelial function and highlight their effects on endothelial nitric oxide synthase (eNOS), the endothelium-dependent hyperpolarising factor (EDHF) pathway(s), as well as on the role of endothelium-derived contracting factors (EDCFs) and adipocyte-derived vasoactive factors such as adiposederived relaxing factor (ADRF).

KW - Diabetes

KW - Endothelial dysfunction

KW - Endothelium-derived contracting factors (EDCF)

KW - Endothelium-derived hyperpolarising factor (EDHF)

KW - Hyperglycaemia

KW - Nitric oxide (NO)

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=77955290312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955290312&partnerID=8YFLogxK

U2 - 10.1007/s00424-010-0807-3

DO - 10.1007/s00424-010-0807-3

M3 - Review article

VL - 459

SP - 977

EP - 994

JO - Pflugers Archiv European Journal of Physiology

JF - Pflugers Archiv European Journal of Physiology

SN - 0031-6768

IS - 6

ER -